SENNOSIDES tablet, film coated

Sennosides by

Drug Labeling and Warnings

Sennosides by is a Otc medication manufactured, distributed, or labeled by REMEDYREPACK INC.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Drug Facts

Active ingredient (in each tablet)

Sennosides 8.6 mg

PURPOSE

Purpose

Laxative

Uses

■ relieves occasional constipation (irregularity)

■ generally produces a bowel movement in 6-12 hours

WARNINGS

Do not use

■ laxative products for longer than 1 week unless directed by a doctor

Ask a doctor before use if you have

■ stomach pain

■ nausea

■ vomiting

■ noticed a sudden change in bowel habits that continues over a period of 2 weeks

Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative.

These may indicate a serious condition.

If pregnant or breast-feeding, ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away. 1-800-222-1222

Directions

■ take preferably at bedtime or as directed by a doctor

Age	Starting Dosage	Maximum Dosage
adults and children 12 years of age and over	2 tablets once a day	4 tablet twice a day
children 6 to under 12 years	1 tablets once a day	2 tablets once a day
children 2 to under 6 years	1/2 tablet once a day	1 tablet twice a day
children under 2 years	ask a doctor	ask a doctor

Other information

• each tablet contains: calcium 25 mg
• each tablet contains: sodium 1 mg
• store at 25ºC (77ºF); excursions permitted between 15º-30ºC (59º-86ºF)

INACTIVE INGREDIENT

croscarmellose sodium, dicalcium phosphate, hypromellose, magnesium stearate, maltodextrin, microcrystalline cellulose, mineral oil, polyethylene glycol, talc

Questions or comments?

Call 1-800-231-4670 Monday-Friday 9AM-5PM EST

SPL UNCLASSIFIED SECTION

TAMPER EVIDENT: DO NOT USE IF PRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING.

Repackaged and Distributed By:

Remedy Repack, Inc.

625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762

PRINCIPAL DISPLAY PANEL

DRUG: Sennosides

GENERIC: Sennosides

DOSAGE: TABLET, FILM COATED

ADMINSTRATION: ORAL

NDC: 70518-3387-0

NDC: 70518-3387-1

NDC: 70518-3387-2

NDC: 70518-3387-3

COLOR: brown

SHAPE: ROUND

SCORE: No score

SIZE: 9 mm

IMPRINT: 1122;1122

PACKAGING: 1 in 1 POUCH

OUTER PACKAGING: 100 in 1 BOX

PACKAGING: 1 in 1 POUCH

OUTER PACKAGING: 100 in 1 BOX

ACTIVE INGREDIENT(S):

• SENNOSIDES 8.6mg in 1

INACTIVE INGREDIENT(S):

• POLYETHYLENE GLYCOL 400
• MICROCRYSTALLINE CELLULOSE
• HYPROMELLOSES
• MAGNESIUM STEARATE
• CROSCARMELLOSE SODIUM
• LIGHT MINERAL OIL
• TALC
• MALTODEXTRIN
• DIBASIC CALCIUM PHOSPHATE DIHYDRATE

INGREDIENTS AND APPEARANCE

SENNOSIDES 
sennosides tablet, film coated

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 70518-3387(NDC:70000-0447)
Route of Administration	ORAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX)	SENNOSIDES	8.6 mg

Inactive Ingredients
Ingredient Name	Strength
POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
HYPROMELLOSES (UNII: 3NXW29V3WO)
MAGNESIUM STEARATE (UNII: 70097M6I30)
CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
LIGHT MINERAL OIL (UNII: N6K5787QVP)
TALC (UNII: 7SEV7J4R1U)
MALTODEXTRIN (UNII: 7CVR7L4A2D)
DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)

Product Characteristics
Color	brown	Score	no score
Shape	ROUND	Size	9mm
Flavor		Imprint Code	1122;1122
Contains

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 70518-3387-0	100 in 1 BOX	03/15/2022
1	NDC: 70518-3387-1	1 in 1 POUCH; Type 0: Not a Combination Product
2	NDC: 70518-3387-2	100 in 1 BOX	03/16/2022
2	NDC: 70518-3387-3	1 in 1 POUCH; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph not final	part334	03/15/2022

Labeler - REMEDYREPACK INC. (829572556)